The NEC Society’s fall webinar series will focus on human milk and the prevention of necrotizing enterocolitis (NEC). For premature and medically fragile babies, breast milk can be a lifesaving intervention. Breast milk protects against NEC, but does not eliminate the risk of NEC. We are just beginning to understand precisely how breast milk protects the health of our most vulnerable neonates.
Our webinar series will explore evidence-based practices for optimizing the use of human milk with babies at increased risk of NEC, as well as practical strategies for partnering with NICU parents.
Registration is now open, please click here to register.
Our October 7 webinar will be led by Dr. Margaret Parker, MD. Dr. Parker is a neonatologist at Boston University and health services researcher of human milk and feeding among preterm infants. She will discuss the use of mother’s own milk to prevent NEC and review evidence-based hospital practices to help mothers of very low birth weight infants.
Our November 18 webinar will be led by Dr. Erin Hamilton Spence, MD, IBCLC. She is a neonatologist and certified-lactation consultant at Cook Children’s Hospital in Fort Worth, TX. She will review the provision of donor human milk in the NICU.
Our December 16 webinar will be led by Dr. Deborah O’Connor, PhD, RD. Dr. O’Connor is a Senior Associate Scientist at the Hospital for Sick Children and Mount Sinai Hospital. She will discuss human milk fortifiers and the clinical trials that examine the effects of different human milk fortifiers on NEC risk.
The NEC Society’s spring webinar series focused on probiotics and attracted more than 330 participants from 22 countries. The slides, recordings, and resources from the Probiotic Webinar Series are available here.
The NEC Society was established in 2014 and is a 501c3 nonprofit organization dedicated to building a world without NEC. Necrotizing enterocolitis is a devastating intestinal disease that primarily affects premature and medically fragile infants. The NEC Society is a multidisciplinary, collaborative organization that brings together patient-families and clinician-scientists committed to improving outcomes for our most vulnerable babies.